Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
5.8M
-
Shares change
-
-511K
-
Total reported value, excl. options
-
$195M
-
Value change
-
-$21.5M
-
Put/Call ratio
-
1.9
-
Number of buys
-
59
-
Number of sells
-
-55
-
Price
-
$33.66
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2016
144 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q1 2016.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.8M shares
of 22.3M outstanding shares and own 26.02% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (1.03M shares), BlackRock Fund Advisors (648K shares), Healthcare Value Capital, LLC (395K shares), VANGUARD GROUP INC (370K shares), SENZAR ASSET MANAGEMENT, LLC (224K shares), Apex Capital Management (196K shares), BlackRock Institutional Trust Company, N.A. (191K shares), Allianz Asset Management AG (186K shares), STATE STREET CORP (179K shares), and Skandinaviska Enskilda Banken AB (publ) (129K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.